JP2016535082A5 - - Google Patents

Download PDF

Info

Publication number
JP2016535082A5
JP2016535082A5 JP2016548443A JP2016548443A JP2016535082A5 JP 2016535082 A5 JP2016535082 A5 JP 2016535082A5 JP 2016548443 A JP2016548443 A JP 2016548443A JP 2016548443 A JP2016548443 A JP 2016548443A JP 2016535082 A5 JP2016535082 A5 JP 2016535082A5
Authority
JP
Japan
Prior art keywords
steatohepatitis
pyrazino
octahydro
quinolin
dioxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016548443A
Other languages
English (en)
Japanese (ja)
Other versions
JP6507336B2 (ja
JP2016535082A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/002846 external-priority patent/WO2015056104A2/en
Publication of JP2016535082A publication Critical patent/JP2016535082A/ja
Publication of JP2016535082A5 publication Critical patent/JP2016535082A5/ja
Application granted granted Critical
Publication of JP6507336B2 publication Critical patent/JP6507336B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016548443A 2013-10-18 2014-10-17 Cbp/カテニン阻害剤を用いる肝線維症の治療 Active JP6507336B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361892606P 2013-10-18 2013-10-18
US61/892,606 2013-10-18
PCT/IB2014/002846 WO2015056104A2 (en) 2013-10-18 2014-10-17 Treatment of hepatic fibrosis using an inhibitor of cbp/catenin

Publications (3)

Publication Number Publication Date
JP2016535082A JP2016535082A (ja) 2016-11-10
JP2016535082A5 true JP2016535082A5 (https=) 2017-12-28
JP6507336B2 JP6507336B2 (ja) 2019-05-08

Family

ID=52828810

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016548443A Active JP6507336B2 (ja) 2013-10-18 2014-10-17 Cbp/カテニン阻害剤を用いる肝線維症の治療

Country Status (5)

Country Link
US (1) US20160263131A1 (https=)
EP (1) EP3057590B1 (https=)
JP (1) JP6507336B2 (https=)
CN (1) CN105899211A (https=)
WO (1) WO2015056104A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6303112B2 (ja) * 2012-12-12 2018-04-04 株式会社PRISM Pharma 肝線維症の予防または治療剤
WO2018022282A1 (en) * 2016-07-29 2018-02-01 Newave Pharmaceutical Inc. Novel therapeutic agents for the treatment of hbv infection
KR20180045213A (ko) * 2016-10-25 2018-05-04 경상대학교산학협력단 Icg-001을 함유하는 섬유증의 예방 또는 치료용 약학 조성물
MA49885A (fr) * 2017-03-15 2020-06-24 Ziylo Ltd Composés macrocycliques
WO2020122022A1 (ja) * 2018-12-10 2020-06-18 東京都 肝機能改善剤
CN115551870B (zh) * 2020-02-11 2025-08-08 圣拉斐尔医院有限公司 乙型肝炎病毒的螺环抑制剂
KR20210153908A (ko) * 2020-06-11 2021-12-20 제이더블유중외제약 주식회사 코로나바이러스감염증-19(covid-19) 치료용 조성물
CN113730403A (zh) * 2021-09-26 2021-12-03 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 化合物kya1797k制备抗hbv病毒药物中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013878A2 (en) 1991-02-07 1992-08-20 Board Of Trustees Of The University Of Illinois Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
CA2141447A1 (en) 1992-08-06 1994-02-17 Michael Kahn Conformationally restricted mimetics of reverse turns and peptides containing the same
US6013458A (en) 1995-10-27 2000-01-11 Molecumetics, Ltd. Reverse-turn mimetics and methods relating thereto
US5929237A (en) 1995-10-27 1999-07-27 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
US6184223B1 (en) 1995-10-27 2001-02-06 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
US6294525B1 (en) 1999-09-01 2001-09-25 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
US7566711B2 (en) * 2001-10-12 2009-07-28 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7915251B2 (en) * 2005-03-18 2011-03-29 Institute For Chemical Genomics Alpha-helix mimetics and methods relating to the treatment of fibrosis
WO2007056593A2 (en) 2005-11-08 2007-05-18 Choongwae Pharma Corporation α-HELIX MIMETICS AND METHOD RELATING TO THE TREATMENT OF CANCER STEM CELLS
US20080009500A1 (en) 2005-11-08 2008-01-10 Michael Kahn Alpha-helix mimetics and methods relating to the treatment of fibrotic disorders
JP5530427B2 (ja) * 2008-06-06 2014-06-25 株式会社PRISM Pharma アルファへリックスミメティック及び関連の方法
CN102186853A (zh) 2008-10-14 2011-09-14 株式会社棱镜生物实验室 治疗癌症α-螺旋模拟物
EP2427451B1 (en) 2009-05-07 2019-03-20 PRISM BioLab Co., Ltd. Alpha helix mimetics and methods relating thereto
WO2011127164A2 (en) * 2010-04-08 2011-10-13 Fate Therapeutics, Inc. Pharmaceutical compositions to treat fibrosis
WO2012115286A1 (en) * 2011-02-25 2012-08-30 Prism Biolab Corporation Alpha helix mimetics and methods relating thereto
JP6303112B2 (ja) * 2012-12-12 2018-04-04 株式会社PRISM Pharma 肝線維症の予防または治療剤

Similar Documents

Publication Publication Date Title
JP2016535082A5 (https=)
EP3400285A4 (en) METHOD FOR IMPROVING MILK PRODUCTION BY ADMINISTERING MICROBIAL CONSORTIA
EA201492214A1 (ru) Ингибиторы вируса гепатита с
MX2018000688A (es) Triciclicos sustituidos y metodo para usarlos.
EA201490228A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
CN103717571B8 (zh) 9‑氨基甲基取代的四环素类化合物
SG10201805231WA (en) 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
EA201690223A1 (ru) Ингибиторы фактора в комплемента на основе производных пиперидинилиндола и их применение
EA201491028A8 (ru) Способ получения замещенных 5-фтор-1н-пиразолопиридинов
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
CN109843873A (zh) 炔代杂环化合物、其制备方法及其在医药学上的应用
MX347692B (es) Inhibidores del virus de la hepatitis c.
CY1124251T1 (el) Παραγωγα καρβοξαμιδιου
EA201692542A1 (ru) Индановые и индолиновые производные и их применение в качестве активаторов растворимой гуанилатциклазы
MX377202B (es) Derivado basado en 1,2-naftoquinona y metodo de preparacion del mismo.
WO2014036502A8 (en) Tetracycline compounds
JP2017061576A5 (https=)
EA201990095A1 (ru) КОНДЕНСИРОВАННЫЕ ТИОФЕНОВЫЕ ПРОИЗВОДНЫЕ, ПРИЕМЛЕМЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ NAPI-IIb
PH12017500558A1 (en) 4'-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus rna replication
WO2012137227A3 (en) Solid forms of antiretroviral compounds and anti-oxidative acids, processes for preparation and pharmaceutical compositions thereof
MX2015013224A (es) Inhibidores macrociclicos y biciclicos del virus de la hepatitis c.
EA201692298A1 (ru) Производные карбоксамидов
EA201700356A1 (ru) Новые циклопропанбензофуранилпиридопиразиндионы
WO2015052568A3 (en) Solid forms of curcumin and derivatives thereof